| Literature DB >> 25237641 |
Mohaddese Mahboubi1, Mohsen Taghizadeh2, Nastaran Kazempour1.
Abstract
BACKGROUND: Pycnocycla spinosa (P. spinosa) a member of the Umbelliferae family is traditionally used for treatment of different ailments.Entities:
Keywords: Antimicrobial Activity; Antioxidant Activity; Extract; Pycnocycla spinosa
Year: 2014 PMID: 25237641 PMCID: PMC4165177 DOI: 10.17795/jjnpp-13859
Source DB: PubMed Journal: Jundishapur J Nat Pharm Prod ISSN: 1735-7780
Total Phenolic Content, Total Flavonoid Content and Antioxidant Capacity of Pycnocycla spinosa Extracts [a]
| Extract | Yield, w/w% | TPC, mg/g | TFC, mg/g | DPPH, IC50 μg/mL | ΒCB, I% |
|---|---|---|---|---|---|
|
| 1.7 | 33.9 | 3.8 | 550 | 36.3 |
|
| 1.14 | 57.8 | 24.4 | 145 | 49.6 |
|
| 1.0 | 57.7 | 30.6 | 82 | 60 |
a Abbreviations: BCB, β-carotene/linoleic acid bleaching; DPPH, 1,1-diphenyl-2-picrylhydrazyl; TFC, total flavonoid content; TPC, total phenolic content.
The Antimicrobial Activity of Pycnocycla spinosa Extracts [a, b, c]
| Water | Ethanol | Methanol | Antibiotic | |||||
|---|---|---|---|---|---|---|---|---|
| MIC | MLC | MIC | MLC | MIC | MLC | MIC | MLC | |
|
| * | * | 6.4 | 12.8 | * | * | 0.25 | 0.25 |
|
| * | * | 12.8 | * | 25.6 | * | 0.25 | 0.5 |
|
| 25.6 | * | 3.2 | * | 6.4 | * | 0.5 | 1 |
|
| * | * | 25.6 | 25.6 | 25.6 | * | 0.25 | 0.5 |
|
| * | * | 25.6 | 25.6 | 25.6 | * | 0.125 | 0.25 |
|
| * | * | 25.6 | * | 25.6 | * | 1 | 2 |
|
| * | * | 25.6 | * | 25.6 | * | 1 | 2 |
|
| * | * | 25.6 | * | 3.2 | 6.4 | 0.5 | 1 |
|
| 25.6 | 25.6 | 1.6 | 3.2 | 25.6 | * | 0.25 | 0.25 |
|
| 0.8 | 1.6 | 3.2 | 3.2 | 3.2 | 6.4 | 0.25 | 0.5 |
|
| * | * | 3.2 | 6.4 | 25.6 | 25.6 | 2 | 4 |
|
| 6.4 | 6.4 | 6.4 | 6.4 | 25.6 | * | 0.5 | 1 |
|
| 25.6 | * | 25.6 | 25.6 | 25.6 | * | 0.25 | 0.5 |
|
| * | * | 25.6 | * | 25.6 | * | 0.25 | 0.5 |
|
| * | * | 25.6 | * | 25.6 | * | 1 | 2 |
|
| * | * | 25.6 | 25.6 | 25.6 | 25.6 | 0.25 | 0.25 |
|
| 25.6 | * | 25.6 | 25.6 | 25.6 | * | 0.25 | 0.5 |
|
| * | * | 25.6 | * | 25.6 | * | 0.25 | 0.5 |
|
| * | * | 25.6 | * | 25.6 | * | 0.25 | 0.5 |
|
| 25.6 | * | 3.2 | 3.2 | 25.6 | 25.6 | 0.125 | 0.25 |
|
| 25.6 | 25.6 | 1.6 | 1.6 | 6.4 | 6.4 | 0.25 | 8 |
|
| * | * | 25.6 | 25.6 | 25.6 | 25.6 | 0.125 | 0.25 |
|
| 25.6 | 25.6 | 25.6 | 25.6 | 25.6 | 25.6 | 0.25 | 0.5 |
|
| * | * | 25.6 | 25.6 | 25.6 | 25.6 | 0.5 | 1 |
|
| * | * | 25.6 | 25.6 | 25.6 | * | 0.5 | 1 |
|
| 25.6 | * | * | 25.6 | 25.6 | 25.6 | 0.5 | 0.5 |
a Abbreviations: MIC, minimal inhibitory concentrations; MLC, minimal lethal concentrations.
b Vancomycin, gentamycin and amphotericin B for Gram-positive and Gram negative bacteria and fungi, respectively.
c *, ≥ 52.1 mg/mL.